Role of interleukin-6 in elastase-induced lung inflammatory changes in mice

Experimental Lung Research

Volumn 36, Issue 6, 2010, Pages 362-372

  Tasaka, Sadatomo ^a   Inoue, Ken Ichiro ^b   Miyamoto, Keisuke ^a   Nakano, Yasushi ^a   Kamata, Hirofumi ^a   Shinoda, Hiromi ^a   Hasegawa, Naoki ^a   Miyasho, Taku ^c   Satoh, Masahiko ^d   Takano, Hirohisa ^b   Ishizaka, Akitoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^c RAKUNO GAKUEN UNIVERSITY   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

apoptosis; elastase; emphysema; IL 6; MMP 12

Indexed keywords

CYTOKINE; ELASTASE; EOTAXIN; INTERLEUKIN 6; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHACHOLINE; PANCREATIC ELASTASE; PHOSPHATE BUFFERED SALINE; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG LAVAGE; LUNG MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; STATISTICAL SIGNIFICANCE; UPREGULATION; WILD TYPE; AIRWAY RESISTANCE; ANIMAL; BREATHING MECHANICS; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INHALATION TEST; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

AIRWAY RESISTANCE; ANIMALS; APOPTOSIS; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LUNG; LUNG COMPLIANCE; MATRIX METALLOPROTEINASE 12; MICE; MICE, KNOCKOUT; PANCREATIC ELASTASE; PNEUMONIA; PULMONARY EMPHYSEMA; RESPIRATORY MECHANICS; TIME FACTORS;

EID: 77954960884     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902141003678590     Document Type: Article

References (30)

1. Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-773.
2. Ishikawa T, Aoshiba K, Yokohori N, Nagai A: Macrophage colony-stimulating factor aggravates rather than regenerates emphysematous lungs in mice. Respiration. 2006;73:538-545.
3. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-688.
4. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164:1896-1903.
5. Park CS, Chung SW, Ki SY, Lim GI, Uh ST, Kim YH, Choi DI, Park JS, Lee DW, Kitaichi M: Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia. Am J Respir Crit Care Med. 2000;162:1162-1168.
6. Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Ogawa Y, Yamada W, Shiraishi Y, Hasegawa N, Fujishima S, Takano H, Ishizaka A: Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol. 2008;38:566-571.
7. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA: Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128:1995-2004.
8. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015-1022.
9. Kuhn C 3rd, Homer RJ, Zhu Z,Ward N, Flavell RA, Geba GP, Elias JA: Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol. 2000;22:289-295.
10. Takahashi S, Nakamura H, Seki M, Shiraishi Y, Yamamoto M, Furuuchi M, Nakajima T, Tsujimura S, Shirahata T,Nakamura M, Minematsu N, Yamasaki M, Tateno H, Ishizaka A: Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L882-L890.
11. Hegab AE, Kubo H, Yamaya M, Asada M, He M, Fujino N, Mizuno S, Nakamura T: Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol Ther. 2008;16:1417-1426.
12. Naruse I, Keino H, Kawarada Y: Antibody against singlestranded DNA detects both programmed cell death and druginduced apoptosis. Histochemistry. 1994;101:73-78.
13. Nishimoto N, Kishimoto T: Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol. 2004;4:386-391.
14. Ammit AJ, Moir LM, Oliver BG, Hughes JM, Alkhouri H, Ge Q, Burgess JK, Black JL, Roth M: Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2007;292:L199-L206.
15. Johnston RA, Schwartzman IN, Flynt L, Shore SA: Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol. 2005;288:L390-L397.
16. Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Morita T, Sato M, Yoshino S, Yoshikawa T, Tohyama C: Protective role of interleukin-6 in coagulatory and hemostatic disturbance induced by lipopolysaccharide in mice. Thromb Haemost. 2004;91:1194-1201.
17. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du YF, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000;22:535-542.
18. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB: Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax. 2006;61:10-16.
19. Kishimoto T: The biology of interleukin-6. Blood. 1989;74:1-10.
20. Kolsum U, Roy K, Starkey C, Borrill Z, Truman N, Vestbo J, Singh D: The repeatability of interleukin-6, tumor necrosis factor-α, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulm Dis. 2009;4:149-156.
21. Oritani K, Tomiyama Y, Kincade PW, Aoyama K, Yokota T, Matsumura I, Kanakura Y, Nakajima K, Hirano T, Matsuzawa Y: Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells. Blood. 1999;93:1346-1354.
22. Kida H, Yoshida M, Hoshino S, Inoue K, Yano Y, Yanagita M, Kumagai T, Osaki T, Tachibana I, Saeki Y, Kawase I: Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol. 2005;288:L342-L349.
23. Lee JS, Rosengart MR, Kondragunta V, Zhang Y, McMurray J, Branch RA, Choi AM, Sciurba FC: Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stableCOPD: a cross-sectional cohort study. Respir Res. 2007;8:64.
24. MillerM, Ramsdell J, Friedman PJ, Cho JY, RenvallM, Broide DH: Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol. 2007;120:1118-1125.
25. Shapiro SD: Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:621-632.
26. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ: Alveolar macrophagemediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. AmJ Physiol Lung Cell Mol Physiol. 2002;283:L867-L873.
27. Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, Planquois JM, Delaval P, Lagente V: Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res. 2005;54:31-36.
28. Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, Pauwels RA, Brusselle GG: Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax. 2006;61:196-201.
29. Le Qúement C, Gúenon I, Gillon JY, Valença S, Cayron- Elizondo V, Lagente V, Boichot E: The selective MMP- 12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol. 2008;154:1206-1215. (Pubitemid 351992055)
30. Manoury B, Nenan S, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V: The absence of reactive oxygen species production protects mice against bleomycininduced pulmonary fibrosis. Respir Res. 2005;6:11.